UBS Group set a CHF 300 price objective on Roche Holding Ltd. Genussscheine (VTX:ROG) in a research report report published on Monday, Borsen Zeitung reports. The firm currently has a buy rating on the healthcare company’s stock.
ROG has been the subject of a number of other research reports. Goldman Sachs Group set a CHF 325 target price on shares of Roche Holding Ltd. Genussscheine and gave the stock a buy rating in a research report on Tuesday, July 30th. Credit Suisse Group set a CHF 300 price objective on shares of Roche Holding Ltd. Genussscheine and gave the company a neutral rating in a research report on Friday, July 26th. Jefferies Financial Group restated a buy rating on shares of Roche Holding Ltd. Genussscheine in a research report on Thursday, August 29th. Bank of America set a CHF 320 price objective on shares of Roche Holding Ltd. Genussscheine and gave the company a buy rating in a research report on Friday, September 13th. Finally, HSBC set a CHF 225 price objective on shares of Roche Holding Ltd. Genussscheine and gave the company a sell rating in a research report on Thursday, August 22nd. Two analysts have rated the stock with a sell rating, two have given a hold rating and ten have assigned a buy rating to the company’s stock. The company presently has an average rating of Buy and a consensus target price of CHF 293.29.
Roche Holding Ltd. Genussscheine has a 1 year low of CHF 214.30 and a 1 year high of CHF 273.
Rogers Corporation designs, develops, manufactures, and sells engineered materials and components worldwide. The company's Advanced Connectivity Solutions segment offers circuit materials and solutions for connectivity applications in wireless communications infrastructure, automotive, connected devices, wired infrastructure, consumer electronics, and aerospace/defense.
Further Reading: What is the price-to-earnings growth (PEG) ratio?
Receive News & Ratings for Roche Holding Ltd. Genussscheine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. Genussscheine and related companies with MarketBeat.com's FREE daily email newsletter.